SAHMRI Annual Scientific Meeting 2018

Eadie, L. (Participant)

Acute Lymphoblastic Leukaemia Group

Activity: Other

Description

Tavakoli PS, Eadie LN, Heatley SL, White DL.
The dual SYK/JAK inhibitor cerdulatinib demonstrates in vitro efficacy against a novel MYB-TYK2 fusion protein in acute lymphoblastic leukaemia cells.
Poster Presentation
Adelaide, South Australia

Period	25 Oct 2018 → 26 Oct 2018